Diamyd Medical Receives U.S. FDA Fast Track Designation for Diamyd (rhGAD65/alum)

February 15, 2024 Diamyd Medical announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Diamyd® (rhGAD65/alum) that is being investigated to improve glycemic control in recently diagnosed stage 3...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials